Trial intelligence / Profile preview

Antidepressants in Muscle Type Temporomandibular Disorders

NCT04777838Phase 3Unknown

Sponsor
University of Coimbra
Start
Mar 2021
Primary completion
May 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of citalopram, amitriptyline in temporomandibular joint disorders (TMD), sponsored by University of Coimbra. Status: unknown.

02

Drugs

citalopramamitriptyline
03

Conditions

temporomandibular joint disorders (TMD)

Beyond the preview

Go deeper on NCT04777838.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04777838.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call